News
IQV
275.15
-1.32%
-3.69
Weekly Report: what happened at IQV last week (1102-1106)?
Weekly Report · 1d ago
Centene Corp. Stock Slips 6.0%, Underperforms Peers
Dow Jones · 4d ago
IQVIA Holdings (IQV) Is Getting Fresh Attention, What Is Behind It?
Simply Wall St · 4d ago
How Investors May Respond To IQVIA Holdings (IQV) Raised 2026 Guidance
Simply Wall St · 5d ago
Centene Corp. Stock Rises 12.6%, Outperforms Peers
Dow Jones · 6d ago
IQVIA-Linked Kidney Transplant Study Targets Disease Recurrence
TipRanks · 6d ago
Gartner Inc. Stock Sheds 13.2%, Underperforms Peers
Dow Jones · 11/03 21:32
Weekly Report: what happened at IQV last week (1026-1030)?
Weekly Report · 11/02 10:16
Why IQVIA Holdings (IQV) Is Getting Attention Today
Simply Wall St · 10/30 12:37
IQVIA Holdings Price Target Raised to $307.00/Share From $288.00 by TD Cowen
Dow Jones · 10/29 17:34
IQVIA Holdings Is Maintained at Buy by TD Cowen
Dow Jones · 10/29 17:34
TD Cowen Maintains Buy on IQVIA Holdings, Raises Price Target to $307
Benzinga · 10/29 17:24
IQVIA’s QUVIVIQ Pregnancy Registry Termination: What It Means for Sleep-Drug Investors
TipRanks · 10/29 16:30
Artisan Global Value Fund Q3 2026 Portfolio Discussion
Seeking Alpha · 10/29 15:20
Iqvia price target raised to $307 from $288 at TD Cowen
TipRanks · 10/29 13:11
Leerink Partners Reaffirms Their Buy Rating on IQVIA Holdings (IQV)
TipRanks · 10/29 12:24
Earnings Beat Could Be A Big Moment For IQVIA Stock
Simply Wall St · 10/29 07:34
Labcorp Holdings Inc. Stock Rallies 8.8%, Outperforms Peers
Dow Jones · 10/28 20:33
IQVIA Holdings Price Target Raised to $325.00/Share From $295.00 by JP Morgan
Dow Jones · 10/28 19:19
IQVIA Holdings Is Maintained at Overweight by JP Morgan
Dow Jones · 10/28 19:19
More
Webull provides a variety of real-time IQV stock news. You can receive the latest news about Iqvia Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About IQV
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Commercial Solutions and Research & Development Solutions. Its commercial solutions provide mission critical information, advanced analytics, technology solutions, health care provider services (including contract sales), and patient engagement services to the Company’s life science clients. Its research & development solutions primarily serve biopharmaceutical customers, provide outsourced clinical research, clinical trial and real-world research related services. The Company offers clinical products, commercial products, compliance, safety, reg products, real world products, and others. Its clinical products include planning suite, grant plan, site suite, clinical trial payments, investigator site portal, one home for sites, patient engagement suite and others.